.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Moodys
Argus Health
Cerilliant
Colorcon
Mallinckrodt
Fuji
Express Scripts
QuintilesIMS
Chinese Patent Office

Generated: September 25, 2017

DrugPatentWatch Database Preview

Nesiritide recombinant - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nesiritide recombinant and what is the scope of nesiritide recombinant patent protection?

Nesiritide recombinant
is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nesiritide recombinant. One supplier is listed for this compound.

Summary for Generic Name: nesiritide recombinant

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Clinical Trials: see list1,552
Drug Prices:see low prices
DailyMed Link:nesiritide recombinant at DailyMed

Pharmacology for Ingredient: nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 2001RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 2001► Subscribe► Subscribe
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 2001► Subscribe► Subscribe
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Johnson and Johnson
US Army
UBS
Citi
Cantor Fitzgerald
Queensland Health
McKinsey
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot